vTv Therapeutics (VTVT) Current Assets (2014 - 2026)

vTv Therapeutics has disclosed Current Assets across 13 years of filings, most recently posting $98.8 million for Q1 2026.

• Current Assets for Q1 2026 came in at $98.8 million, up 209.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $98.8 million (up 209.59% YoY), and the FY2025 annual result was $89.9 million, up 135.86% from the prior year.
• Current Assets came in at $98.8 million for Q1 2026 at vTv Therapeutics, up from $89.9 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $99.5 million in Q3 2025 to a low of $10.1 million in Q3 2023.
• The 5-year median for Current Assets is $30.6 million (2022), against an average of $40.2 million.
• Across the five-year window, Current Assets plunged 64.82% in 2023 and jumped 324.28% in 2024, its largest moves.
• vTv Therapeutics' Current Assets stood at $27.1 million in 2022, then slumped by 60.67% to $10.7 million in 2023, then soared by 257.63% to $38.1 million in 2024, then jumped by 135.86% to $89.9 million in 2025, then climbed by 9.92% to $98.8 million in 2026.
• The last three Current Assets figures came in at $98.8 million (Q1 2026), $89.9 million (Q4 2025), and $99.5 million (Q3 2025), per Business Quant data.